Should you buy ASND stock?
Last updated:
Based on market data through , StockInvest.us rates Ascendis Pharma A/S (ASND) as a Sell Candidate with a technical score of -2.73 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Up 2.31%
- 3-month trend forecast Up 12.41%
- High gross margin of 88.2%
- Low bankruptcy risk (Altman Z-Score: 4.40)
- Bullish trend confirmed on both short and long timeframes
Ascendis Pharma A/S stock price up 0.0822% on Monday
(Market data through Aug 10, 2026)
The Ascendis Pharma A/S stock price gained 0.0822% on the last trading day (Monday, 10th Aug 2026), rising from $255.41 to $255.62. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.73% from a day low at $250.87 to a day high of $257.73. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 100 thousand more shares were traded than the day before. In total, 423 thousand shares were bought and sold for approximately $108.25 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.41% during the next 3 months and, with a 90% probability hold a price between $256.25 and $324.90 at the end of this 3-month period.
ASND Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, August 03, 2026, and so far it has risen 5.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ascendis Pharma A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $256.89. On a fall, the stock will find some support from the short-term average at $248.15. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss for Ascendis Pharma A/S stock
On the downside, the stock finds support just below today's level from accumulated volume at $230.83 and $224.11. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ascendis Pharma A/S finds support just below today's level at $230.83. If this is broken, then the next support from accumulated volume will be at $224.11 and $205.81.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $6.86 between high and low, or 2.73%. For the last week, the stock has had daily average volatility of 3.04%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ASND) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Ascendis Pharma A/S to open at $254.74, and during the day (based on 14 day Average True Range), to move between $251.60 and $259.64, which gives a possible trading interval of +/-$8.03 (+/-3.19%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 3.19% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $260.75 (2.01%) than the support at $230.83 (9.70%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Ascendis Pharma A/S will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is $1.71. We will update the financials statements for Ascendis Pharma A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.93% in the first trading day after earnings release.
Is Ascendis Pharma A/S stock A Buy?
Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-2.725
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $254.74 ( 0.344%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ASND Performance
Trading levels for ASND
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 261.60 | 2.34% |
| R2 | 258.98 | 1.31% |
| R1 | 257.36 | 0.681% |
| Price | 255.62 | |
| S1 | 252.12 | -1.37% |
| S2 | 250.50 | -2.00% |
| S3 | 247.88 | -3.03% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 277.18 | 8.43% |
| R2 | 261.58 | 2.33% |
| R1 | 260.75 | 2.01% |
| Price | 255.62 | |
| S1 | 230.83 | -9.70% |
| S2 | 224.11 | -12.33% |
| S3 | 205.81 | -19.49% |
FAQ
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.
Buy ASND